Welcome to our dedicated page for Renavotio news (Ticker: RIII), a resource for investors and traders seeking the latest updates and insights on Renavotio stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Renavotio's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Renavotio's position in the market.
Renavotio, Inc. (OTCQB:RIII) announced a new purchase order worth $1.8 million for surgical gloves from a medical distributor, following a $2.15 million order made in February 2021. The orders are contingent on the buyer's product inspection and final payment. Renavotio Infratech, the company’s subsidiary, is ramping up production of personal protective equipment (PPE). CEO Billy Robinson expressed enthusiasm about the company's progress and plans to solidify Renavotio's presence in the PPE market. For further engagement, the company invites participants to their Q1 Virtual Investor Summit.
Renavotio, Inc. (OTCQB:RIII) will present at the Q1 Virtual Investor Summit on March 24, 2021, at 2:30 PM ET. CEO Billy Robinson and Board Advisor Kevin Harrington will discuss the company's diverse infrastructure opportunities, including personal protective equipment, 5G, and utility management. This conference connects small-cap companies with qualified investors and features over 300 potential investors. For registration, visit here.
Renavotio, Inc. (OTCQB:RIII) has announced a $2,150,000 initial purchase order for surgical gloves from a PPE supplier, pending product inspection and 60% payment. The company, through its subsidiary, Renavotio Infratech, is focusing on PPE markets, producing masks, gloves, and gowns. They plan to use VerifyMe's anti-counterfeit technology for a future order of 2 million boxes. CEO Billy Robinson highlighted this order as a step towards building significant manufacturing relationships and combating counterfeit PPE products amid ongoing pandemic challenges.
Renavotio, Inc. (OTCQB:RIII) announced a new Marketing and Distribution Agreement with VerifyMe, Inc. (NASDAQ:VRME) to enhance its personal protective equipment (PPE) offerings. The partnership will focus on integrating VerifyMe's anti-counterfeiting technology, addressing the significant issue of counterfeit PPE products amid soaring demand. Renavotio aims to provide verified authenticity for its PPE items, including masks and gloves. This collaboration is expected to drive potential revenue growth and improve consumer protection against counterfeit goods in both U.S. and global markets.
FAQ
What is the market cap of Renavotio (RIII)?
